Drug-induced urolithiasis;Les lithiases urinaires d'origine médicamenteuse

Therapie

Volumn 56, Issue 6, 2001, Pages 743-750

  Cohen Solal, F ^a   Abdelmoula, J ^a   Hoarau, M P ^a   Jungers, P ^a   Lacour, B ^a   Daudon, M ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Calcium oxalate; Calculi; Drug induced lithiasis; Indinavir; Infrared spectroscopy; Silica; Uric acid.; Urinary

Indexed keywords

ADALGUR; ALLOPURINOL; ALUMINUM HYDROXIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANALGESIC AGENT; ANTRAFENINE; ATTAPULGITE; BAKTEKOD; CALCIUM; CARBONATE DEHYDRATASE INHIBITOR; CEFTRIAXONE; CORTICOSTEROID; COTRIMOXAZOLE; CYCLOTERIAM; FLOCTAFENINE; GELOPECTOSE; GLAFENINE; GRAMIDIL; HYDROCHLOROTHIAZIDE PLUS TRIAMTERENE; INDINAVIR; ISOBAR; LAXATIVE; MEFENAMIC ACID; NAFTIDROFURYL OXALATE; PHENAZOPYRIDINE; PIRIDOXILATE; PTERIDINE DERIVATIVE; SALAZOPIRINE; SALAZOSULFAPYRIDINE; SILICON DIOXIDE; SULFADIAZINE; SULFAGUANIDINE; SULFAMETHOXAZOLE; SULFONAMIDE; SULINDAC; TRIAMTERENE; UNINDEXED DRUG; URICOSURIC AGENT; VITAMIN D; ZAMOCILLINE;

CHEMICAL COMPOSITION; CONFERENCE PAPER; DISEASE CLASSIFICATION; DIURESIS; DRUG INDUCED DISEASE; DRUG WITHDRAWAL; FRANCE; HUMAN; INFRARED SPECTROSCOPY; METABOLISM; PRIORITY JOURNAL; STONE ANALYSIS; URINE PH; UROLITHIASIS; VITAMIN SUPPLEMENTATION;

FRANCE; HUMANS; PHARMACEUTICAL PREPARATIONS; SPECTROPHOTOMETRY, INFRARED; URINARY CALCULI;

EID: 0035714006     PISSN: 00405957     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (52)

1. Les lithiases médicamenteuses
2. Calculs pyéliques d'acides glaféniques chez deux patientes traitées de façon prolongée par des analgésiques
3. Piridoxilate-induced calcium oxalate nephrolithiasis: A nation-wide epidemiologic evaluation of incidence
4. Urinary stones in HIV-1-positive patients treated with indinavir
5. Calcul urinaire de silice secondaire à l'absorption de gélopectose chez l'enfant
6. Sulfadiazine-induced multiple urolithiasis and acute renal failure in a patient with AIDS and toxoplasma encephalitis
7. Iatrogenic urinary calculi, detection and identification by X-ray diffraction
8. Drug-induced renal stone: Incidence, clinical expression and stone analysis
9. Les lithiases médicamenteuses
10. Incidence and analysis of drug-induced urinary stones
11. Indinavir nephropathy
12. Indinavir crystalluria
13. Protease inhibitors and urolithiasis
14. Nonopaque crystal deposition causing ureteric obstruction in patients with HIV undergoing indinavir therapy
15. Coliques néphrétiques sous indinavir
16. Crystalluria and urinary tract abnormalities associated with indinavir
17. Indinavir crystal deposits associated with tubulointerstitial nephropathy
18. Detection of indinavir crystals in urine: Dependence on method of analysis
19. Triamterene-induced nephrolithiasis
20. Triamterene nephrolithiasis
21. Triamtérène et lithiases rénales
22. Formes cliniques de la lithiase urinaire
23. Handling of triamterene by the isolated perfused rat kidney
24. Metabolic fate and solubility of triamterene. Not an explanation for triamterene nephrolithiasis
25. Urolithiasis and renal pathology after administration of sulfapyridine
26. Sulfonamide renal calculus
27. Reversible acute renal failure due to sulfonamide-induced lithiasis in an AIDS patient
28. Harnkonkremente nach langzeitsulfonamiden
29. Cristalluries médicamenteuses: Mythes et réalités
30. Bilateral acetylsulfapyridine nephrolithiasis associated with chronic sulfasalazine therapy
31. Spurious stones
32. Calculo renal de silice en un hombre (undecima obsevacion mundial)
33. Silica stones in the urinary bladder
34. Silicate urolithiasis
35. Calculs urinaires de silice. A propos d'un cas
36. Identification d'un métabolite de la floctafénine dans un calcul urinaire
37. Harnsteinbildung durch dihydrotachysterol-Uberdodierung
38. Nephrolithiasis from calcium supplementation
39. Urolithiasis in patients with end-stage renal failure
40. Modèles de cristallisation
41. Whewellite et weddellite: Vers des étiopathogénies différentes. Intérêt du typage morphologique des calculs
42. Urinary calculi: Review of classification methods and correlations with etiology
43. Metabolic urinary correlates of calcium oxalate dihydrate in renal stones
44. Calculus formation and ureteral colic following acetazolamide therapy
45. Urinary calculi with methazolamide therapy
46. Urine composition and stone formation during treatment with acetazolamide
47. Newer anticonvulsant drugs: Role of pharmacology, drug interactions and adverse reactions in drug choice
48. Topiramate: A new antiepileptic drug
49. Piridoxilate-associated calcium oxalate urinary calculi: A new metabolic drug-induced nephrolithiasis
50. Piridoxilate-induced calcium oxalate calculi: A new drug-induced metabolic nephrolithiasis
51. Laxative abuse as a cause for ammonium urate renal calculi
52. Adverse reactions associated with ticrynafen use